Teva's migraine med given marketing authorization
US regulator approves Teva's migraine drug
AbbVie pressures Biohaven in migraine prevention with FDA approval for its CGRP blockbuster-to-be Qulipta | FiercePharma
FDA approves Teva's Ajovy autoinjector for treatment of migraine | Pharmafile
AbbVie drug approval sets up competition with Biohaven in migraine prevention - MedCity News
Teva shares rally as FDA approves troubled drugmaker's migraine treatment | The Times of Israel
FDA Approves Teva's Ajovy Injection for the Prevention and Treatment of Migraine in Adults | Specialty Pharma Journal
FDA just approved the first drug to prevent migraines. Here's the story of its discovery—and its limitations | Science | AAAS
Teva seeks FDA approval for migraine drug fremanezumab - Pharmaceutical Business review
Teva's AJOVY Receives FDA Approval for the Treatment of Migraine in Adults with Monthly and Quarterly
Teva wins FDA OK for crucial migraine drug - PMLiVE
Teva Announces FDA Approval of AJOVY® (fremanezumab-vfrm) Injection Autoinjector | Business Wire
Teva Pharmaceutical: Shares rise after FDA approves new migraine drug | Business News,The Indian Express
Xconomy: Teva Wins FDA Nod for Migraine Drug, Sets Price in Line with Amgen's
Teva Pharmaceutical | $TEVA Stock | Shares Rally After Winning FDA Approval for Migraine Therapy - Warrior Trading News
Teva Receives FDA Approval for Migraine Autoinjector | Ctech
Teva Submits Potential Moneymaker Migraine Drug for FDA Approval | Ctech
Teva Shares Pop as FDA Approves Its Migraine Drug - TheStreet
US FDA eases Teva headache with Ajovy approval
Teva migraine patch gets close FDA scrutiny for causing burns and scarring | FiercePharma
Lilly, Teva Meet Endpoints for Cluster Headache & Migraine; Amgen Gains FDA Approval of Aimovig
Teva discontinues trial of Ajovy for episodic cluster headache - Pharmaceutical Technology
